Cysteamine: Clinical Trials

5 trials of Cysteamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Recruiting 1

Follow Cysteamine: new trials by email Literature Review of Cysteamine trials Research Report on Cysteamine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)
Mercaptamine - Cystinosis
Phase 3CompletedRECORDATI GROUP52020-09-012024-02-05
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Ceftriaxone + Macrolide, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam + Macrolide - Respiratory Tract Diseases, Influenza (Pandemic)
Phase 3RecruitingUMC Utrecht200002016-04-112026-11-04
Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis
RP103, Cystagon® - Cystinosis
Phase 3CompletedAmgen412013-01-312024-12-27
Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)
Cysteamine Bitartrate Delayed-release Capsules - Cystinosis
Phase 3CompletedAmgen602010-08-272024-12-27
Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
Cystagon® (Cysteamine Bitartrate), Cysteamine Bitartrate Delayed-release Capsules (RP103) - Cystinosis
Phase 3CompletedAmgen432010-06-012024-12-19

Conditions studied

Cystinosis (4)  ·  Rare Diseases (3)  ·  Metabolic Diseases (2)  ·  COVID-19 (1)  ·  Community-Acquired Pneumonia (1)  ·  Influenza, Human (1)  ·  Lung Diseases (1)  ·  Pneumonia (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Sponsors

Amgen (3)  ·  RECORDATI GROUP (1)  ·  UMC Utrecht (1)

Countries

France (5)  ·  Netherlands (4)  ·  United States (4)  ·  Belgium (3)  ·  Italy (3)  ·  United Kingdom (3)  ·  Germany (2)  ·  Australia (1)  ·  Canada (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Estonia (1)  ·  Finland (1)  ·  Hungary (1)

Top investigators

Colin McArthur, Dr (1)  ·  Derek Angus, Prof (1)  ·  John Marshall, Prof (1)  ·  Lennie Derde, MD (1)  ·  Luis Felipe Reyes, MD, MSc, PhD (1)  ·  Marc Bonten, Prof (1)  ·  Steve Webb, Prof (1)

Results publications

PMID 24948347, PMID 32267771, PMID 32876697, PMID 33394942, PMID 33509275, PMID 33631065, PMID 34251506, PMID 34351721, PMID 34351722, PMID 34473343, PMID 34606578, PMID 35315874, PMID 36525245, PMID 36942550, PMID 36967714, PMID 37039790, PMID 37256341, PMID 37489818, PMID 37877585, PMID 37888913, PMID 40261382, PMID 40360262, PMID 42823695

NIH funding

2015 (1), 2023 (1)